We recently compiled a list of the Billionaire Larry Robbins’ Long-Term Stock Picks. In this article, we are going to take a look at where The Cigna Group (NYSE:CI) stands against Larry Robbins’ other long-term stock picks.

We recently compiled a list of the 15 Best Large-Cap Value Stocks to Buy in 2025. In this article, we are going to take a look at where The Cigna Group (NYSE:CI) stands against the other large-cap value stocks.

Buying $1000 In CI: If an investor had bought $1000 of CI stock 20 years ago, it would be worth $11,032.06 today based on a price of $289.04 for CI at the time of writing.

An arbitrator has determined Prime Therapeutics violated federal and state antitrust laws against the AIDS Healthcare Foundation (AHF) and independent pharmacies. | Prime Therapeutics, a PBM owned by Blue Cross plans,

Cigna and Centene were among a dozen companies that appeared on the initial JPM agenda that have bowed out of the conference.

Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2024 financial results on Thursday, January 30, 2025, and will host a conference call the same day.

I live in Michigan and my auto insurance requires letters from Cigna to prove I have Qualified Health Coverage i.e. stating that my Cigna health coverage is Primary payer in case of an auto accident.

In a report released yesterday, Lance Wilkes from Bernstein maintained a Buy rating on Cigna (CI – Research Report), with a price target of

Investment analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for The Cigna Group in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst S. James forecasts that the health services provider will post earnings per share of $31.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average acquisition cost for dozens of specialty generic drugs, bringing in more than $7.

In this article, we are going to take a look at where The Cigna Group (NYSE:CI) stands against the other large-cap value stocks. Why is this Portfolio Manager Cautiously Optimistic? The market ...